Chapter 4: Pharmacokinetics Flashcards

1
Q

Pharmacokinetics

A

the study of drug movement throughout the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

4 basic pharmacokinetic processes

A
  1. absorption
  2. distribution
  3. metabolism
  4. excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Absorption

A

Movement of a drug from site of administration to the bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Distribution

A

Movement of a drug through the bloodstream, across the interstitial spaces, and into cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metabolism (biotransformation)

A

Inactivation of drugs

usually takes place in the liver and catalyzed by the cytochrome P450 system of enzymes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Excretion

A

Movement of drugs out of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

elimination

A

metabolism plus excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

phospholipids

A

the basic membrane structure consisting of a double layer of molecules (lipids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 ways drugs cross cell membranes

A

1) channels or pores
2) a transport system
3) direct penetration. (Most common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

channels or pores

A
  • Very narrow

- Very few drugs use this method (ions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

transport system

A
  • Carriers that move drugs from one side of the membrane to the other
  • Some require energy
  • All are selective
  • P-glycoprotein is one that exists on many cells:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

P-Glycoprotein

A
A transporter that can pump certain drugs out of epithelial cells back into the intestinal lumen.
Exist in:
1. Liver – drugs into bile
2. Kidney – drugs into urine
3. Placenta – drugs into maternal blood
4. Brain – drugs into bloodstream
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

direct penetration

A
  1. Method for most drugs
  2. Dissolve in phospholipid membrane to move through
  3. Molecules must be lipid soluble
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Polar molecules

A

Molecules with no net electrical charge, but have uneven distribution of electrons.
Positive and negative charges on opposite sides of the molecule.
Large polar molecules will not dissolve in non-polar substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ions

A

Molecules that have a net electrical charge (+ or -). Unable to cross membranes unless very small.

  • Quaternary ammonium compounds
  • pH-dependent ionization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Quaternary ammonium compounds

A

Carry a positive charge at all times

Because of the charge, these compounds are unable to cross most membranes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

pH-Dependent Ionization

A

Compounds that become ionized depending upon the pH of the environment (acids and bases)
Acids tend to give up hydrogen in alkaline environment
Bases tend to accept hydrogen in acidic environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ionization

A

the process of an acid giving up a proton or a base accepting a proton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ion Trapping (pH Partitioning)

A

pH may differ on two sides of a membrane
Drugs will accumulate on the side of a membrane favoring their ionization
Acidic drugs will accumulate on alkaline side; alkaline drugs will accumulate on the acidic side

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Absorption

A

Movement from site of administration to blood.

Enhanced by: rapid dissolve, high lipid solubility, large surface area, and high blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Embolism

A

blood vessel blockage at a site distant from the point of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Oral absorption

A

Can be from the stomach, the intestine, or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Oral Barriers

A

1) the layer of epithelial cells that lines the GI tract.

2) the capillary wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what happens to drugs following their absorption from the GI tract

A

Must pass through the liver (via the portal blood), enter the inferior vena cava then reach general circulation. Some drugs undergo extensive hepatic metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

bioavailability

A

The quantity of a drug available in the body after it is administered.
100% is recorded when drugs are administered IV.
Many drugs administered by mouth go through first-pass metabolism therefore, less than 100%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Enteric-Coated

A

Material designed to dissolve in the small intestine but not the stomach.

1) to protect drugs from acid and pepsin in the stomach
2) to protect the stomach from drugs that can cause gastric discomfort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Sustained-Release

A

Capsules filled with tiny spheres that contain the actual drug; the individual spheres have coatings that dissolve at variable rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Distribution

A

the movement of drugs throughout the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Exiting the Vascular System

A

Drugs in the vascular system pass between cells rather than through them, movement into the interstitial space is not impeded.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Blood-Brain Barrier (BBB)

A

There are tight junctions between cells of the capillary walls in the CNS that prevent drug passage. Only drugs that are lipid soluble or have a transport system can cross the BBB.

31
Q

Placental Drug Transfer

A

Lipid-soluble, nonionized compounds readily pass from maternal blood into fetus blood. In contrast, ionized, highly polar, or protein bound compounds are largely excluded—as are drugs that are substrates for P-glycoprotein.

32
Q

Protein Binding

A

Drugs can form reversible bonds with plasma albumin. While bound, drug molecules cannot leave the vascular system

33
Q

Hepatic Drug-Metabolizing Enzymes

A

Most drug metabolism that takes place in the liver is performed by the hepatic microsomal enzyme system, also known as cytochrome P450, a key component of this enzyme system.

34
Q

cytochrome P450 (CYP450)

A

3 of the 12 families called CYP1, CYP2, and CYP3 metabolize drugs.
Some are CYP450 (inducers)
Some reduce CYP450 activity (inhibitors)

35
Q

6 consequences of drug metabolism

A
  • Accelerated renal excretion
  • Drug inactivation
  • Increased therapeutic action
  • Activation of “prodrugs”
  • Increased toxicity
  • Decreased toxicity
36
Q

Accelerated Renal Drug Excretion

A

MOST IMPORTANT
Kidney cannot excrete drugs that are very lipid soluble
Metabolism can convert drugs into water-soluble forms

37
Q

prodrug

A

compound that is pharmacologically inactive as administered and then undergoes conversion to its active form via metabolism

38
Q

Special Considerations in Drug Metabolism

A
Age
Induction
Inhibition
First-Pass Effect
Nutritional Status
Competition Between Drugs
39
Q

Induction

A

Process of stimulating enzyme synthesis

40
Q

Inhibition

A

Decrease rates of enzyme synthesis

41
Q

First-Pass Effect

A

Drugs administered through the enteral or rectal routes undergo first-pass metabolism in the liver.
Sublingual, intravenous, and intramuscular routes bypasses the first-pass metabolism, and bioavailability is high.
A higher drug dose will be needed if an oral formulation is prescribed.

42
Q

Enterohepatic Recirculation

A

A drug is transported from the liver into the duodenum (via the bile duct) and then back to the liver (via the portal blood)

43
Q

Excretion

A

the removal of drugs from the body

44
Q

Renal Drug Excretion Steps

A

1) glomerular filtration
2) passive tubular reabsorption
3) active tubular secretion

45
Q

Glomerular Filtration

A

Renal excretion begins at the glomerulus of the kidney tubule surrounded by Bowman’s capsule.
Small pores perforate the wall and as blood flows, fluids, small molecules, and drugs are forced through the pores into the urine.
Large molecules and drugs bound to albumin cannot be filtered out.

46
Q

Minimum Effective Concentration (MEC)

A

The plasma drug level below which there is no therapeutic effect.

47
Q

Toxic Concentration

A

The plasma drug level at which toxic effects are identified.

48
Q

Therapeutic Range

A

The range of doses between MEC and toxic concentration
Wide range = more safe (acetaminophen)
Narrow range = less safe (lithium, digoxin)

49
Q

Plateau

A

The time at which dosing equals drug elimination between doses.
When the same dose is delivered repeatedly, it typically takes 4 half lives to reach plateau

50
Q

IV administration advantages

A

rapid onset
precise control over the amount of drug
suitability for use with large volumes
suitability for irritant drugs

51
Q

IV administration disadvantages

A
high cost
difficult
inconvenience
danger because of irreversibility
potential for fluid overload
infection
embolism
52
Q

IM & Subcutaneous administration advantages

A

suitability for insoluble and slow release

53
Q

IM & Subcutaneous administration disadvantages

A

inconvenience

potential for discomfort

54
Q

Oral administration advantages

A

easy
convenient
economic
safe

55
Q

Oral administration disadvantages

A

high variability, possible inactivation by stomach acid digestive enzymes

56
Q

Oral medication

A

Exercise decreases blood flow to the stomach
Stress can slow gastric emptying time
A high-fat meal slows gastric emptying time.
Hunger and fasting delay drug absorption
Food can stimulate the production of gastric acid.

57
Q

Protein Bound Drugs

A

When two protein-bound drugs are given, they compete for sites, causing more free drug to be released. Possible drug toxicity can result.

58
Q

Breast Milk

A

Lipid-soluble drugs may be expressed, but water-soluble, ionic, protein-bound drugs will not.

59
Q

Elderly patients

A

have less gastric acidity, which causes slow absorption of drugs in the stomach

60
Q

NOT lipid soluble molecules

A

Ions

Polar molecules

61
Q

IV Barriers

A

None

62
Q

IM Barriers

A

capillary wall

63
Q

Cytochrome (CYP450) Inducers

A

Increase the activity of CYP450
Increase metabolism of drugs
Drug levels will fall
Dosages need to be increased

64
Q

Cytochrome (CYP450) Inhibitors

A

Decrease the activity of CYP450
Decreased metabolism of drugs
Drug levels rise
Dosages need to be reduced

65
Q

Activation of “prodrugs”

A

Administered drug is inactive (pro-drug)

Metabolism converts pro-drug into active form

66
Q

Passive tubular reabsorption

A

Blood vessels leaving glomerulus run close to renal tubules.
Lipid soluble drugs are reabsorbed into blood.
Non-lipid soluble drugs remain in renal tubule.
Lipid soluble drugs that are metabolized into polar molecules cannot be reabsorbed.

67
Q

Active tubular secretion

A

Active transport pumps remove drugs from blood into tubules.
Tubules contain pumps for organic acids and organic bases.
P-glycoprotein also pumps drugs

68
Q

Factors that influence excretion

A
  • pH
  • Competition for active tubular transport
  • Age
69
Q

Competition for active tubular transport

A
  • Multiple drugs competing for use of the same active transport mechanism slows excretion.
  • Toxic levels of drugs can occur.
70
Q

Peak concentration

A

highest level – usually measured within 1 hour AFTER administration

71
Q

Trough concentration

A

lowest level – usually measured within 30 minutes BEFORE administration

72
Q

Loading dose

A

Large initial dose followed by smaller maintenance doses.
Usually done for medications with very long half life.
Reduces time to plateau.

73
Q

Decline of drug levels

A

When dosing is discontinued, 94% of the drug will be eliminated after 4 half-lives